442 related articles for article (PubMed ID: 28040265)
1. Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury.
Oh CJ; Ha CM; Choi YK; Park S; Choe MS; Jeoung NH; Huh YH; Kim HJ; Kweon HS; Lee JM; Lee SJ; Jeon JH; Harris RA; Park KG; Lee IK
Kidney Int; 2017 Apr; 91(4):880-895. PubMed ID: 28040265
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity.
Kim J; Long KE; Tang K; Padanilam BJ
Kidney Int; 2012 Jul; 82(2):193-203. PubMed ID: 22437413
[TBL] [Abstract][Full Text] [Related]
3. PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.
Li S; Wu P; Yarlagadda P; Vadjunec NM; Proia AD; Harris RA; Portilla D
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F572-80. PubMed ID: 14612380
[TBL] [Abstract][Full Text] [Related]
4. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
[TBL] [Abstract][Full Text] [Related]
5. Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity.
Nozaki Y; Kinoshita K; Hino S; Yano T; Niki K; Hirooka Y; Kishimoto K; Funauchi M; Matsumura I
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F899-909. PubMed ID: 25651561
[TBL] [Abstract][Full Text] [Related]
6. Reducing Oxidative Stress and Inflammation by Pyruvate Dehydrogenase Kinase 4 Inhibition Is Important in Prevention of Renal Ischemia-Reperfusion Injury in Diabetic Mice.
Khang AR; Kim DH; Kim MJ; Oh CJ; Jeon JH; Choi SH; Lee IK
Diabetes Metab J; 2024 May; 48(3):405-417. PubMed ID: 38311057
[TBL] [Abstract][Full Text] [Related]
7. LIGHT deficiency aggravates cisplatin-induced acute kidney injury by upregulating mitochondrial apoptosis.
Yang Y; Meng L; Wu S; Li Y; Zhong Y; Xu F; Zhou XC; Li GQ; Xu GL; Peng KF
Int Immunopharmacol; 2020 Dec; 89(Pt A):106999. PubMed ID: 33045563
[TBL] [Abstract][Full Text] [Related]
8. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
9. 3-MCPD 1-Palmitate Induced Tubular Cell Apoptosis In Vivo via JNK/p53 Pathways.
Liu M; Huang G; Wang TT; Sun X; Yu LL
Toxicol Sci; 2016 May; 151(1):181-92. PubMed ID: 27008853
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
11. Caspase-11 promotes cisplatin-induced renal tubular apoptosis through a caspase-3-dependent pathway.
Miao N; Wang B; Xu D; Wang Y; Gan X; Zhou L; Xue H; Zhang W; Wang X; Lu L
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F269-F279. PubMed ID: 28446458
[TBL] [Abstract][Full Text] [Related]
12. Suppression of mitochondrial biogenesis through toll-like receptor 4-dependent mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling in endotoxin-induced acute kidney injury.
Smith JA; Stallons LJ; Collier JB; Chavin KD; Schnellmann RG
J Pharmacol Exp Ther; 2015 Feb; 352(2):346-57. PubMed ID: 25503387
[TBL] [Abstract][Full Text] [Related]
13. Autophagy in proximal tubules protects against acute kidney injury.
Jiang M; Wei Q; Dong G; Komatsu M; Su Y; Dong Z
Kidney Int; 2012 Dec; 82(12):1271-83. PubMed ID: 22854643
[TBL] [Abstract][Full Text] [Related]
14. Intervention of mitochondrial activity attenuates cisplatin-induced acute kidney injury.
Yang Y; Fu Y; Wang P; Liu S; Sha Y; Zhang Y; Zhang A; Jia Z; Ding G; Huang S
Int Urol Nephrol; 2019 Jul; 51(7):1207-1218. PubMed ID: 31020626
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
Santos NA; Catão CS; Martins NM; Curti C; Bianchi ML; Santos AC
Arch Toxicol; 2007 Jul; 81(7):495-504. PubMed ID: 17216432
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and genetic inhibition of fatty acid-binding protein 4 alleviated cisplatin-induced acute kidney injury.
Tan Z; Guo F; Huang Z; Xia Z; Liu J; Tao S; Li L; Feng Y; Du X; Ma L; Fu P
J Cell Mol Med; 2019 Sep; 23(9):6260-6270. PubMed ID: 31286669
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase 2 alleviates mitochondrial dysfunction by promoting PGC-1α-mediated biogenesis in acute kidney injury.
Li J; Shi X; Chen Z; Xu J; Zhao R; Liu Y; Wen Y; Chen L
Cell Death Dis; 2023 Jan; 14(1):45. PubMed ID: 36670098
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo.
Terada Y; Inoue K; Matsumoto T; Ishihara M; Hamada K; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Horino T; Karashima T; Tamura K; Fukuhara H; Fujimoto S; Tsuda M; Shuin T
PLoS One; 2013; 8(12):e80850. PubMed ID: 24324635
[TBL] [Abstract][Full Text] [Related]
20. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.
Li S; Basnakian A; Bhatt R; Megyesi J; Gokden N; Shah SV; Portilla D
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F990-8. PubMed ID: 15280156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
